These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. On the prediction of statistical parameters in high-throughput screening using resampling techniques. Ilouga PE; Hesterkamp T J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175 [TBL] [Abstract][Full Text] [Related]
4. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review. Shun TY; Lazo JS; Sharlow ER; Johnston PA J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066 [TBL] [Abstract][Full Text] [Related]
5. Cheminformatics approaches to analyze diversity in compound screening libraries. Akella LB; DeCaprio D Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings. Wu Z; Liu D; Sui Y J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390 [TBL] [Abstract][Full Text] [Related]
8. The Interweaving of Cheminformatics and HTS. Kümmel A; Parker CN Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979 [TBL] [Abstract][Full Text] [Related]
9. Hit finding: towards 'smarter' approaches. Langer T; Hoffmann R; Bryant S; Lesur B Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852 [TBL] [Abstract][Full Text] [Related]
10. Enhanced HTS hit selection via a local hit rate analysis. Posner BA; Xi H; Mills JE J Chem Inf Model; 2009 Oct; 49(10):2202-10. PubMed ID: 19795815 [TBL] [Abstract][Full Text] [Related]
11. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads. Bergsdorf C; Ottl J Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747 [TBL] [Abstract][Full Text] [Related]
12. A new method with flexible and balanced control of false negatives and false positives for hit selection in RNA interference high-throughput screening assays. Zhang XD J Biomol Screen; 2007 Aug; 12(5):645-55. PubMed ID: 17517904 [TBL] [Abstract][Full Text] [Related]
14. Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin. Jenkins JL; Kao RY; Shapiro R Proteins; 2003 Jan; 50(1):81-93. PubMed ID: 12471601 [TBL] [Abstract][Full Text] [Related]
15. Use of high-throughput mass spectrometry to reduce false positives in protease uHTS screens. Adam GC; Meng J; Rizzo JM; Amoss A; Lusen JW; Patel A; Riley D; Hunt R; Zuck P; Johnson EN; Uebele VN; Hermes JD J Biomol Screen; 2015 Feb; 20(2):212-22. PubMed ID: 25336354 [TBL] [Abstract][Full Text] [Related]
16. Case studies of minimizing nonspecific inhibitors in HTS campaigns that use assay-ready plates. Liu Y; Beresini MH; Johnson A; Mintzer R; Shah K; Clark K; Schmidt S; Lewis C; Liimatta M; Elliott LO; Gustafson A; Heise CE J Biomol Screen; 2012 Feb; 17(2):225-36. PubMed ID: 21940710 [TBL] [Abstract][Full Text] [Related]
17. 3D models of epithelial-mesenchymal transition in breast cancer metastasis: high-throughput screening assay development, validation, and pilot screen. Li Q; Chen C; Kapadia A; Zhou Q; Harper MK; Schaack J; LaBarbera DV J Biomol Screen; 2011 Feb; 16(2):141-54. PubMed ID: 21297102 [TBL] [Abstract][Full Text] [Related]